Comparative efficacy and safety of quetiapine versus other atypical antipsychotics for behavioral and psychological symptoms in Alzheimer’s disease: a systematic review and meta-analysis

Frontiers in Psychiatry | New and Recent Articles ·
Mind & Mental Health Switzerland

BackgroundThe management of behavioral and psychological symptoms of dementia (BPSD) in Alzheimer’s disease (AD) remains a significant challenge. While atypical antipsychotics are used, their comparative efficacy and safety, particularly for quetiapine, are not well-established within a homogeneous AD population. This meta-analysis aimed to directly compare the efficacy and safety of quetiapine…

Read original article on Frontiers in Psychiatry | New and Recent Articles →

Related news